1. Home
    /
  2. IPO
Hexagon Nutrition IPO

Hexagon Nutrition IPO

Consumer Food
upcoming
₹13,986Min. investment
  1. Pre-apply
    TBA
  2. Bid start
    5 Jun
  3. Bid end
    9 Jun
  4. Allotment
    10 Jun
  5. Release of funds
    11 Jun
  6. Demat transfer
    11 Jun
  7. Listing
    12 Jun

Hexagon Nutrition Limited IPO Details

SectorConsumer Food
Price range₹42.00 – ₹45.00
IPO type
Regular
Lot size333 shares
Issue size₹139Cr
Market Cap
₹553.1CrLower than sector avg
RevenueApr 20NaN - Mar 20FY
₹324.9CrLower than sector avg
Growth rate3Y CAGR
8.01%

Hexagon Nutrition Limited IPO Overview

Hexagon Nutrition IPO date

Hexagon Nutrition IPO will open for subscription on June 05, 2026, and the closing date for the IPO is June 9, 2026. After this, investors are expected to be updated about the allotment status on June 10, 2026.

Investors who have been allotted shares can expect them to be credited to their demat account on June 11, 2026. The shares will be listed on the NSE and the BSE on Friday, June 12, 2026.

Hexagon Nutrition IPO price band

Hexagon Nutrition IPO is a complete offer for sale. The IPO price band has been set between ₹42 and ₹45 per share. Interested investors can choose a price within this band to apply for the IPO.

The IPO is a book-building issue, comprising an offer for sale of ₹138.8 crore. Hexagon Nutrition IPO listing price will be determined on June 12, 2026. The listing price is the price at which a company’s shares debut on the stock exchanges.

Hexagon Nutrition IPO lot size

Hexagon Nutrition IPO details have been declared. The minimum lot size for an application is 333 shares, and the investor would have to apply for a minimum of 1 lot. Meanwhile, the IPO issue size is approximately ₹138.8 crore.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector
Nestle India LtdNestle India Ltd
Varun Beverages LtdVarun Beverages Ltd
Britannia Industries LtdBritannia Industries Ltd
Revenue
Higher revenue means strong sales and good market demand
This IPO
₹324.9Cr
This sector
₹1,087.57Cr
Compare with companies
PAT
Higher PAT means strong profitability and efficient cost management
This IPO
₹24.3Cr
This sector
₹78.55Cr
Compare with companies
Market cap
Higher market cap means strong confidence but may suggest overvaluation
This IPO
₹553.1Cr
This sector
₹7,146.66Cr
Compare with companies
P/E ratio
Lower ratio usually means stock is undervalued
This IPO
25.71
This sector
43.50
Compare with companies
D/E ratio
Lower ratio usually means fewer liabilities
This IPO
0.14
This sector
0.91
Compare with companies

Objectives

Carry out the offer for sale
The IPO is a complete offer-for-sale (OFS). Net IPO proceeds will go to selling shareholders.
Listing on stock exchanges
The company want to achieve the benefits of listing its shares on the stock exchanges.

Strength and Weakness

Market-leading nutrition platform

The company stands out among the select few fully integrated nutrition firms in India, owing to its strengths in research and development, manufacturing, quality control, and marketing, positioning itself as a top company in premixes and UN-related micronutrient programmes. Its diverse operations in consumer-oriented wellness, business-to-business premixes, and therapeutic nutrition, combined with its distinct in-house premix raw materials, create an advantage over its competitors, such as Abbott, Nestlé India, etc.

Strong global nutrition play

The company's successful creation of recurring brands of clinical nutrition has been bolstered by regulatory clearances in 14+ jurisdictions, a sales force of 167 members serving around 20,843 healthcare professionals, and e-commerce generating 6.51% of its 9MFY26 revenues.

Repeat revenue visibility

Business stability through long-term relationships between the company and its customers is seen from its repeated customers generating ₹148.6 crore or 55.54% of total 9MFY26 sales, which include ₹118.6 crore (44.32%) generated by repeated B2B2C customers.

Innovation-driven product pipeline

The company’s growth is driven by innovation, having two research and development centres, 12 specialists working on innovation, 11 products launched in the past 3+ years, and 9 products currently in the pipeline, with stable investment in R&D at 0.68–0.91% during FY23-FY25.

About Hexagon Nutrition Limited

Hexagon Nutrition was incorporated in the year 1993 as a micronutrient formulations company and has gradually moved up the value chain by building its own brands in the health, wellness and clinical nutrition space.
In FY24, the company further expanded its portfolio with the launch of a new brand, “NUTRONE”. It has a presence across India and exports products to 75+ countries. Hexagon Nutrition has three domestic manufacturing facilities, located in Nashik (Maharashtra), Chennai (Tamil Nadu) and Tuticorin (Tamil Nadu) and one International manufacturing facility in Tashkent (Uzbekistan). The manufacturing plants located in Chennai and Tuticorin are located within an SEZ, providing the advantage of proximity to ports and duty-free importation. Its integrated and standardised manufacturing 270 processes enable it to maintain the quality of the products.
In FY25, the company operated with an installed monthly capacity of 835 MT for dry premix, 42.5 MT for liquid premix, 59.65 MT for MNPs, 680 MT for RUFs and 110 MT for clinical nutrition products under a two-shift operation model. During FY25, actual production stood at 259.2 MT for dry premix, 7.96 MT for liquid premix, 5.99 MT for MNPs, 193.88 MT for RUFs and 51.71 MT for clinical nutrition products. Capacity utilisation remained moderate across most categories, with clinical nutrition having the highest utilisation at 47.01%, followed by dry premix at 31.04% and RUFs at 28.51%.
The company’s business is divided into three key segments. The branded wellness and clinical nutrition (B2C) segment contributed ~30% of 9MFY26 revenue and includes brands such as PENTASURE for adult wellness and clinical nutrition, OBESIGO for weight management, and PEDIAGOLD for pediatric nutrition. The Premix Formulations (B2B2C) segment accounted for ~51% of 9MFY26 revenue and caters to leading Indian and multinational FMCG companies by supplying customised vitamin and mineral premixes for food and beverage fortification. The therapeutic nutrition or ESG segment contributed 17.93% of 9MFY26 revenue and includes Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs), which are used to address malnutrition among children and support the nutritional requirements of pregnant and lactating women.
The company has built a diversified customer base across its segments. In the B2C segment, it caters to individual consumers and healthcare professional-led recommendations. In the B2B2C segment, it supplies customised premixes to domestic and multinational FMCG companies, while in the ESG segment, its customers include government bodies, humanitarian organisations and international development agencies. During FY25, the company had 275 repeat customers in the B2B2C segment, 7 in the B2C segment and 12 in the ESG segment. In FY25, 38.66% revenue came from domestic sales while exports made up 61.25%. In FY25, Maharashtra, Karnataka and Tamil Nadu were key contributors in revenue, and the UAE, Ethiopia and Indonesia were the main exporting countries.
The Indian nutrition market is estimated at ₹1,52,800 crore in CY25 and is expected to grow to ₹2,81,400 crore by CY30, a CAGR of 13%. This exponential growth will be supported by rising demand for protein supplements, functional and immunity-focused foods, along with premiumisation and clean-label trends. The growth opportunity in Indian markets is largely supported by the high level of nutritional deficiency in India. More than 50% of women and children suffer from anaemia, around 35% of the population is deficient in Vitamin A, and nearly 57% of women in the 15 to 49 age group are anaemic. These health concerns continue to drive demand for fortified food products, micronutrient supplements and clinical nutrition solutions across the country.
Government-led nutrition and food fortification programs are also creating a large and steady market opportunity for companies. Going ahead, the company wants to grow its current branded segments by augmenting its online sales through enhanced digital marketing and exploring newer online platforms. It intends to increase its national footprint by expanding to Tier 2 and Tier 3 cities over the period of the next 3 to 5 years. The industry continues to benefit from rising health awareness, increasing disposable incomes and growing demand for functional foods and dietary supplements, which could support long-term growth for the company.
Now, Hexagon Nutrition is launching its initial public offering (IPO), which is complete offer-for-sale of ₹138.8 crore only. The company’s shares will be listed on the NSE and BSE.

How to pre-apply for Hexagon Nutrition IPO?

You can pre-apply for Hexagon Nutrition IPO on Upstox. The pre-application for this IPO, which means the pre-apply open date, usually begins a day before the IPO opens for subscription.
Follow these steps to pre-apply for the IPO:
  • Login to your Upstox account, using your six-digit PIN
  • After successfully logging in, click on ‘Discover’
  • On the Discover tab, you will find the ‘Invest in IPO’ section
  • Under the Invest in IPO section, look for the ‘Hexagon Nutrition IPO’ tab and click on it
  • Now fill in all the required information, like ‘bid price’ and ‘lot size’
  • Confirm and click on ‘Pre-Apply’
  • Accept the mandate on your UPI app

How to apply for Hexagon Nutrition IPO?

If you are interested in this investment opportunity but unsure how to apply for Hexagon Nutrition IPO, here are the steps that you need to follow.
When the public issue opens for subscription, one can follow this step-by-step guide on how to apply for Hexagon Nutrition IPO on Upstox:
  • Log in to your Upstox account, using your six-digit PIN
  • After logging in, click on ‘Discover’
  • On the ‘Discover’ tab, you will find the ‘Invest in IPO’ section
  • Under the Invest in IPO section, look for the ‘Hexagon Nutrition IPO’ tab and click on it
  • Now fill in all the required information, like ‘bid price’ and ‘lot size’
  • Confirm and click on ‘Apply’
  • Accept the mandate on your UPI app

**How to check the Hexagon Nutrition IPO allotment status? **

When the allotment process is completed, you can check the status of your application on the Upstox app. Share allotment is generally completed on the next working day after an IPO closes.
Here’s a step-by-step guide on how to check the Hexagon Nutrition IPO allotment status:
  • Login to your Upstox account, using your six-digit PIN
  • After logging in, click on ‘Discover’
  • On the ‘Discover’ page, you will find the ‘Invest in IPO’ section
  • Under the Invest in IPO section, you will find the ‘View all’ option
  • Once you click on ‘View all’, you will be directed to the ‘IPO’ tab
  • In the ‘IPO’ tab, click on ‘My applications’
  • In ‘My applications’, under the History section, your Hexagon Nutrition IPO allotment status will be mentioned.

Frequently asked questions

How to invest in the Hexagon Nutrition IPO ?

Investors can apply for the Hexagon Nutrition IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Hexagon Nutrition IPO ?

The issue size of the Hexagon Nutrition IPO is 139 Cr.

What is 'pre-apply' for Hexagon Nutrition IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Hexagon Nutrition IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Opens on 5 Jun 2026